The present invention relates generally to a diagnostic device including a prognostic
assay for parameters which are indicative of a condition or event associated with the systemic vasculature. More particularly, the present invention provides an
assay to detect parameters associated with a
vascular disease including cardiovascular,
stroke, pulmonary, renovascular, cerebrovascular, thrombotic or generalized arterial or venous condition or event including acute coronary syndrome such as but not limited to acute
myocardial infarction,
heart failure, atheromoma or a thrombotic condition. The identification of these parameters or more particularly a pattern of parameters enables the diagnosis of a condition or event or the determination of the risk of development of a condition or event associated to the systemic vasculature. Still more particularly, the present invention is directed to a diagnostic device comprising a set of members wherein one or more of said members has or have specific or generic binding partners in a biological sample from an animal including human subject wherein the pattern of binding of the members to the binding partners is indicative, predictive or otherwise associated with a likelihood of a condition or event within the systemic vasculature. The absence of detection of specific or generic binding partners is also of indicative or
predictive value. This is particularly important in cases where patients are unable to communicate advice to a physician on their own condition, such as during
surgery or for patients in a
coma. It is also useful in determining the risk of a
vascular disease including cardiovascular,
stroke, pulmonary, renovascular, cerebrovascular, thrombotic or generalized arterial or venous conditions or events in a healthy subject or a subject entering into an
exposure to risk such as
surgery or
chemotherapy. The present invention is useful inter alia for the identification and / or quantitation of
biochemical markers of conditions or events in the systemic vasculature such as
heart disease, heart disorders, infections of the heart,
stroke and
thrombosis as well as the determination of a risk of development of these conditions including the absence of disorders or absence of risk of the development of a disorder. The assessment of such conditions may be made in a clinical setting, as part of
triage, as part of a
routine testing protocol and / or as a laboratory procedure.